What is the recommended fluid intake for hyponatremia?

Recommended Fluid Intake for Hyponatraemia

For hyponatraemia, fluid restriction—not increased fluid intake—is the cornerstone of management in most cases, with the specific approach determined by volume status and underlying aetiology.

Fluid Restriction Based on Volume Status and Severity

Euvolaemic Hyponatraemia (SIADH)

• Fluid restriction to 1 L/day (approximately 40 mL/hour) is first-line therapy for mild to moderate asymptomatic SIADH, representing the most effective initial intervention 1, 2, 3.
• For patients who fail initial fluid restriction, more aggressive restriction to 500 mL/day may be implemented, with adjustments based on serum sodium response 2.
• Approximately half of SIADH patients do not respond adequately to fluid restriction alone, necessitating second-line therapies such as oral urea or vaptans 2.

Hypervolaemic Hyponatraemia (Heart Failure, Cirrhosis)

• Fluid restriction to 1,000–1,500 mL/day is recommended when serum sodium falls below 125 mmol/L in patients with heart failure or cirrhosis 1, 4, 3.
• Recent evidence from the FRESH-UP trial challenges routine strict fluid restriction in stable chronic heart failure patients, demonstrating that liberal, thirst-guided fluid intake was safe and reduced thirst distress without increasing hospitalizations or mortality 5.
• In cirrhotic patients, sodium restriction (2–2.5 g/day) is more effective than fluid restriction for weight loss, as fluid passively follows sodium 1.

Hypovolaemic Hyponatraemia

• Fluid restriction is contraindicated—these patients require volume expansion with isotonic saline (0.9% NaCl) for volume repletion 1, 6, 3.
• Initial infusion rates of 15–20 mL/kg/hour, followed by 4–14 mL/kg/hour based on clinical response, are appropriate 1.

Severe Symptomatic Hyponatraemia: Active Correction, Not Restriction

• For severe symptomatic hyponatraemia (seizures, altered mental status, coma), hypertonic saline (3% NaCl) is administered as 100 mL boluses over 10 minutes, repeating up to three times at 10-minute intervals until symptoms resolve 1, 2, 3.
• The target is to increase serum sodium by 6 mmol/L over 6 hours or until severe symptoms resolve, but total correction must never exceed 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome 1, 7, 4, 3.
• After initial correction, maintenance fluids should be isotonic (0.9% NaCl), and hypotonic solutions must be avoided 1.

Critical Safety Limits for Sodium Correction

Standard-Risk Patients

• Maximum correction rate: 4–8 mmol/L per 24 hours, not exceeding 10–12 mmol/L in any 24-hour period 1, 7.
• This translates to approximately 0.33 mmol/L per hour, achieved through careful fluid management and frequent monitoring rather than a fixed infusion rate 7.

High-Risk Patients (Cirrhosis, Alcoholism, Malnutrition)

• Maximum correction rate: 4–6 mmol/L per 24 hours, with an absolute ceiling of 8 mmol/L in any 24-hour period 1, 7, 4.
• These patients have a 0.5–1.5% risk of osmotic demyelination syndrome even with careful correction 1.

Monitoring Requirements

• Severe symptoms: check serum sodium every 2 hours during initial correction 1, 7.
• Mild symptoms or asymptomatic patients: check every 4–6 hours during active correction 1, 7.
• If overcorrection occurs (>8 mmol/L in 24 hours), immediately discontinue sodium-containing fluids, switch to D5W (5% dextrose in water), and administer desmopressin to reverse the rapid rise 1, 7.

Common Pitfalls to Avoid

• Never increase fluid intake in hyponatraemia—this worsens dilutional hyponatraemia in SIADH and hypervolaemic states 1, 6.
• Never use fluid restriction in hypovolaemic hyponatraemia or cerebral salt wasting—this worsens outcomes and can precipitate cerebral ischaemia 1.
• Never correct chronic hyponatraemia faster than 8 mmol/L in 24 hours—rapid correction causes osmotic demyelination syndrome, manifesting as dysarthria, dysphagia, oculomotor dysfunction, and quadriparesis 2–7 days after overcorrection 1, 6, 3.
• Never apply universal fluid restriction to all heart failure patients—emerging evidence supports individualised, thirst-guided approaches in stable chronic heart failure 5.

Emerging Evidence on Correction Speed

• A large retrospective cohort study of 13,988 patients with severe hyponatraemia (sodium ≤120 mEq/L) found that faster sodium correction rates (>12 mEq/L in 24 hours) were associated with lower 90-day mortality and delayed neurologic events compared to slow correction (<8 mEq/L), challenging traditional guidelines 8.
• However, this observational data must be weighed against established physiological principles and the known risk of osmotic demyelination syndrome, particularly in high-risk populations 8.